Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker CAI
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 4, 2026 | CAI Caris Life Sciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 14, 2026 | CAI Caris Life Sciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 5, 2026 | CAI Caris Life Sciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 5, 2026 | CAI Caris Life Sciences, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 7, 2026 | CAI Caris Life Sciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 2, 2026 | CAI Caris Life Sciences, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Apr 2, 2026 | CAI Caris Life Sciences, Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 2, 2026 | CAI Caris Life Sciences, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 26, 2026 | CAI Caris Life Sciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 26, 2026 | CAI Caris Life Sciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 12, 2026 | CAI Caris Life Sciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 12, 2026 | CAI Caris Life Sciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 5, 2025 | CAI Caris Life Sciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 30, 2025 | CAI Caris Life Sciences, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Oct 30, 2025 | CAI Caris Life Sciences, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Aug 12, 2025 | CAI Caris Life Sciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
18 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:46 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances